Molecular Analysis Of Bladder Cancer
Active, not recruiting
- Conditions
- Bladder NeoplasmsBladder Cancer
- Registration Number
- NCT00871754
- Lead Sponsor
- Lahey Clinic
- Brief Summary
This is a laboratory study where the investigators hope to look at chromosomal events implicated in bladder cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
- Bladder cancer
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What chromosomal events are associated with bladder cancer progression in NCT00871754?
How do molecular markers in NCT00871754 inform targeted therapies for bladder neoplasms?
What role do FGFR3 and TP53 mutations play in bladder cancer patient stratification?
Are there novel biomarkers for non-invasive bladder cancer detection identified in this study?
How does the molecular analysis in NCT00871754 compare to other bladder cancer genomic studies?
Trial Locations
- Locations (1)
Lahey Clinic
🇺🇸Burlington, Massachusetts, United States
Lahey Clinic🇺🇸Burlington, Massachusetts, United States